[1] 王进进,施辉,董文胜,等.微创钻孔引流联合尿激酶和阿托伐他汀对慢性硬膜下血肿患者术后神经功能及复发率的影响[J].脑与神经疾病杂志,2021,29(4):222-227. [2] Shen J,Shen JG,Song YN.Effect of drilling and drainage combined with atorvastatin on the short-term curative effect and postoperative recurrence of patients with chronic subdural hematoma[J].Modern Practical Medicine,2020,32(6):622-624. [3] Shao BS.The effect of atorvastatin on the recurrence rate of chronic subdural hematoma after drilling and drainage[J].Clinical Research,2020, 28(4):38-40. [4] 张朋. 阿托伐他汀钙辅助治疗对慢性硬膜下血肿患者术后神经功能及复发率的影响[J].河南医学研究,2019,28(14):2599-2600. [5] 陈锐锋,朱安林.微创钻孔引流术联合阿托伐他汀对慢性硬膜下血肿患者术后并发症及复发率的影响[J].安徽医学,2019,40(1):62-65. [6] Zhang CL,Zhu Feng,Chen XF,et al.The curative effect of Yunnan Hongyao capsule combined with atorvastatin in the treatment of postoperative recurrent chronic subdural hematoma and its effect on serum IL-6, VEGF, MMP-9, and D-dimer levels[J].Modern Journal of Integrated Traditional Chinese and Western Medicine,2018,27(28):3090-3093,3097. [7] Xiong XH,Qu DX,Wei XC,et al.The effect of atorvastatin on postoperative recurrence rate of chronic subdural hematoma[J].Stroke and Neurological Diseases,2018,25(2):210-212. [8] 王东挺,张学军,梁伟.阿托伐他汀联合地塞米松对慢性硬膜下血肿患者钻孔引流术后复发的影响[J].中国医学创新,2018,15(8):54-57. [9] Yang YN,Zhang Qian,Gu Zheng,et al.Clinical effect of atorvastatin assisted drilling and drainage in the treatment of patients with chronic subdural hematoma and its influence on serum NSE[J].Chinese Journal of Biochemical Pharmaceutics,2016,36(8):58-60. [10] 郭晖,奉鹏,张慧娟,等.地塞米松联合阿托伐他汀及脑血疏口服液治疗慢性硬膜下血肿行钻孔引流术后患者复发率的探究[J].中华急诊医学杂志,2021,30(6):766-768. [11] 吴月娟. 阿托伐他汀对2型糖尿病血管病变患者的疗效及对血浆黏度,血小板聚集率,血细胞比容和纤维蛋白原水平的水平影响[J].血栓与止血学,2020,26(1):68-70. |